Biochemical injection treatment for discogenic low back pain: A pilot study

Spine Journal

Volumn 3, Issue 3, 2003, Pages 220-226

  Klein, Robert G ^a   Eek, Björn C J ^a   O'Neill, Conor W ^b   Elin, Caren ^c   Mooney, Vert ^d   Derby, Richard R ^b  

^a Department of Orthopedic Medicine ^*  (United States)

^b Spinal Diagnostics and Treatment Center   (United States)

^c Compreh Musculoskeletal Care Center ^*  (United States)

^d US Spine & Sport Foundation   (United States)

Author keywords

Chondroitin sulfate; Dextrose; DMSO; Glucosamine; Injection; Intervertebral disc; Low back pain; Zygapophyseal joint

Indexed keywords

ANALGESIC AGENT; CHONDROITIN SULFATE; CORTICOSTEROID; DIMETHYL SULFOXIDE; GLUCOSAMINE; GLUCOSE; PROTEOGLYCAN;

ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; DISKOGRAPHY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; INJECTION PAIN; INTERVERTEBRAL DISK DISEASE; INTRACTABLE PAIN; LEG PAIN; LOW BACK PAIN; MALE; METHODOLOGY; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOGLYCAN SYNTHESIS; SCORING SYSTEM; SPINE SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME; VERTEBRAL CANAL STENOSIS; VISUAL ANALOG SCALE; INTERVERTEBRAL DISK HERNIA; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; PAIN; TIME;

ADULT; ANALGESICS, NON-NARCOTIC; CHONDROITIN SULFATES; DIMETHYL SULFOXIDE; FEMALE; GLUCOSAMINE; GLUCOSE SOLUTION, HYPERTONIC; HUMANS; INJECTIONS, SPINAL; INTERVERTEBRAL DISK DISPLACEMENT; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0346486744     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-9430(02)00669-1     Document Type: Article

References (32)

1. Mooney V. Presidential address to the International Society for the Study of the Lumbar Spine, Dallas, 1986. Where is the pain coming from? Spine 12 1987 754-759
2. Olmarker K. Blomquist J. Stromberg J. Nannmark U. Thomsen P. Rydevik B. Infammatogenic properties of nucleus pulposus Spine 20 1995 665-669
3. McCarron R.F. Wimpee M.W. Hudkins P.G. Laros G.S. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low back pain Spine 12 1987 760-764
4. Vanharanta H. Guyer R.D. Ohnmeiss D.D. et al. Disc deterioration in low back syndromes. A prospective, multi-center CT/discography study Spine 13 1988 1349-1351
5. Schwarzer A. Aprill C. Derby R. et al. The relative contributions of the disc and zygapophyseal joint in chronic low back pain Spine 19 1995 801-806
6. Guiot B.H. Fessler R.G. Molecular biology of degenerative disc disease Neurosurgery 47 5 2000 1034-1040
7. Buckwalter J.A. Aging and degeneration of the human intervertebral disc Spine 20 11 1995 1307-1314
8. Pearce R.H. Grimmer B.J. Adams M.E. Degeneration and the chemical composition of the human lumbar intervertebral disc J Orthop Res 5 2 1987 198-205
9. Steven R.L. Ryvar R. Robertson W.R. O'Brien J.P. Beard H.K. Biological changes in the annulus fibrosis in patients with low back pain Spine 7 3 1982 223-233
10. Deal C.L. Moskowitz R.W. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate Rheum Dis Clin North Am 25 2 1999 379-395
11. McAlindon T.E. LaValley M.P. Gulin J.P. Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis:a systematic quality assessment and meta-analysis JAMA 283 11 2000 1469-1475
12. Phillipi A.F. Leffler C.T. Leffler S.G. Mosure J.D.C. Kim P.D. Glucosamine, chondroitin and manganese for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study Military Med 164 2 1999 85-91
13. Leeb B.F. Schweitzer H. Montag K. Smolen J.S. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis J Rheumatol 27 1 2000 205-211
14. da Camara C.C. Dowless G.V. Glucosamine sulfate for osteoarthritis Ann Pharmacother 32 5 1998 580-587
15. Reginster J.Y. Deroisy R. Rovati L.C. et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 2001 251-256
16. Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Rel Res 2000 Dec;(381):229-40.
17. Roland M.R. Morris R.M. A study of the natural history of back pain Spine 8 1983 141-144
18. Schofferman J. Slosar P. Reynolds J. Goldwaithe N. Kestler M. A prospective randomized comparison of 270 degree fusions to 360 degree fusions (circumferential fusions) Spine 26 2001 E207-E212
19. Fritzell P. Hagg O. Wessberg P. Nordwall A. 2001 Volvo award in clinical studies: lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Group Spine 26 23 2001 2521-2532
20. Karasek M. Bogduk N. Twelve month follow-up of a controlled trial of intradiscal thermal annuloplasty for back pain due to internal disc disruption Spine 20 2000 2601-2607
21. McDevitt C.A. Proteoglycans of the intervertebral disc In: Ghosh P. (Ed.), The biology of the intervertebral disc 1988 152-170 CRC Press Boca Raton, FL
22. Pugliese G. Pricci F. Locuratolo N. et al. Increased activity of the insulin like growth factor system in mesangial cells cultured in high glucose concentrations. Relation to glucose enhanced extracellular matrix production Diabetologia. 39 7 1996 775-784
23. Reinhold D. Ansorge S. Schleicher E.D. Elevated glucose levels stimulate transforming growth factor-beta (TGF-beta1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells Horm Metab Res 28 6 1996 267-270
24. Ohgi S. Johnson P.W. Glucose modulates growth of gingival fibroblasts and periodontal ligament cells: correlation with expression of basic fibroblast growth factor J Periodontal Res 31 8 1996 579-588
25. DiPaolo S. Gesualdo I. Ranieri E. Grandaliano G. Schena F.P. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet derive growth factor loop in human mesangial cells Am J Pathol 149 6 1996 2095-2106
26. Wakitani S. Imoto K. Kimura T. Hepatocyte growth factor facilitates cartilage repair: full thickness articular cartilage defect studied in rabbit knees Acta Orthop Scand 68 5P 1997 474-480
27. Thompson J.P. Oegema T.R. Bradford D.S. Stimulation of mature canine intervertebral disc by growth factors Spine 16 3 1991 253-260
28. Van Beuningen H.M. Glansbeek H.I. van der Kraan P.M. van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta on both articular cartilage composition and osteophyte formation Osteoarthritis Cartilage 6 5 1998 306-317
29. Oh J.H. Ha H. Yu M.R. Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor beta-1 and fibronectin synthesis Kidney Int 54 6 1998 1872-1878
30. Okuda Y. Adrogue H.J. Nakajima A. et al. Increased production of PDGF by angiotensin and high glucose in human vascular endothelium Life Sci 59 17 1996 1455-1461
31. Walker M. DMSO: nature's healer 1993 Avery Publishing Group Garden City Park, NY
32. Diwan A.D. Parvataneni H.K. Khan S.N. et al. Current concepts in intervertebral disc restoration Orth Clin North Am 31 3 2000 453-463